NAFLD & Diabetes

This feed focuses on Non-Alcoholic Fatty Liver Disease (NAFLD) in diabetic patients, which can lead to increased medical complications, such as cirrhosis.

September 17, 2021

Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland.

United European Gastroenterology Journal
Nina Barner-RasmussenMartti Färkkilä
September 17, 2021

Omarigliptin protects against nonalcoholic fatty liver disease by ameliorating oxidative stress and inflammation.

Journal of Biochemical and Molecular Toxicology
Zeyu LiLianfeng Zhang
September 17, 2021

SYSTEMATIC REVIEW WITH META-ANALYSIS: NON-ALCOHOLIC FATTY LIVER DISEASE AND THE ASSOCIATION WITH PREGNANCY OUTCOMES.

Clinical and Molecular Hepatology
Hydar El JamalyMartin Weltman
September 16, 2021

Evaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease.

The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
Haluk Tarik KaniYusuf Yilmaz
September 16, 2021
Open Access

Lack of miR-379/miR-544 Cluster Resists High-Fat Diet-Induced Obesity and Prevents Hepatic Triglyceride Accumulation in Mice.

Frontiers in Cell and Developmental Biology
Congcong CaoShuiqiao Yuan
September 16, 2021

Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations.

Human Vaccines & Immunotherapeutics
Massimo AndreoniSociety for Infectious and Tropical Diseases (SIMIT)
September 16, 2021
Review

Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements.

Annals of Intensive Care
G MontrucchioL Brazzi
September 16, 2021

Demographic and clinical factors associated with early hospital Coronovirus disease 2019 deaths in a low middle income setting: A record-based analysis of 20,641 deaths from India.

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
Aravind Gandhi PeriyasamyAmarjeet Singh
September 16, 2021
Case Report
Open Access

Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin Antibodies.

AACE Clinical Case Reports
Danielle BrooksNirali A Shah
September 15, 2021

The Thioesterase ACOT1 as a Regulator of Lipid Metabolism in Type 2 Diabetes Detected in a Multi-Omics Study of Human Liver.

Omics : a Journal of Integrative Biology
Marco CavalliClaes Wadelius
September 15, 2021

Advances in Anti-inflammatory Activity, Mechanism and Therapeutic Application of Ursolic Acid.

Mini Reviews in Medicinal Chemistry
Mingzhu LuanQingguo Meng
September 14, 2021
Preprint
Open Access

INTESTINAL GLUCONEOGENESIS IS DOWNREGULATED IN PAEDIATRIC PATIENTS WITH COELIAC DISEASE

MedRxiv : the Preprint Server for Health Sciences
O. KarlsonÅsa Torinsson Naluai

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

© 2021 Meta ULC. All rights reserved
/feed-previews/nafld-diabetes/f8fe47c0-8113-49b6-a878-c1622a9bb497